Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths in the United States. The 5-year survival rates are poor with traditional therapy alone. New scientific advances in technology involving the human genome, including diagnostic tools to inform on tumor-derived acquired (somatic) mutations that...

Descripción completa

Detalles Bibliográficos
Autor principal: Suk, Gretchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881738/
https://www.ncbi.nlm.nih.gov/pubmed/36727019
http://dx.doi.org/10.6004/jadpro.2022.13.8.5

Ejemplares similares